COVID-19: breaking down a global health crisis

SI Mallah, OK Ghorab, S Al-Salmi, OS Abdellatif… - Annals of clinical …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is the second pandemic of the twenty-first
century, with over one-hundred million infections and over two million deaths to date. It is a …

Coronary microvascular dysfunction pathophysiology in COVID‐19

J Yin, S Wang, Y Liu, J Chen, D Li, T Xu - Microcirculation, 2021 - Wiley Online Library
Recently, accumulating evidence has highlighted the role of endothelial dysfunction in
COVID‐19 progression. Coronary microvascular dysfunction (CMD) plays a pivotal role in …

Cardiac markers of multisystem inflammatory syndrome in children (MIS-C) in COVID-19 patients: A meta-analysis

Y Zhao, J Patel, Y Huang, L Yin, L Tang - The American Journal of …, 2021 - Elsevier
Objective A meta-analysis of laboratory cardiac markers for multisystem inflammatory
syndrome in children (MIS-C) was performed in patients with coronavirus disease 2019 …

Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study

D Collard, NS Nurmohamed, Y Kaiser, LF Reeskamp… - BMJ open, 2021 - bmjopen.bmj.com
Objectives Recent reports suggest a high prevalence of hypertension and diabetes in
COVID-19 patients, but the role of cardiovascular disease (CVD) risk factors in the clinical …

Types of myocardial injury and mid-term outcomes in patients with COVID-19

A Kini, D Cao, M Nardin, S Sartori… - … Journal-Quality of …, 2021 - academic.oup.com
Aims To evaluate the acute and chronic patterns of myocardial injury among patients with
coronavirus disease-2019 (COVID-19), and their mid-term outcomes. Methods and results …

Cardiac injury and mortality in patients with Coronavirus disease 2019 (COVID-19): insights from a mediation analysis

A Cipriani, F Capone, F Donato, L Molinari… - Internal and emergency …, 2021 - Springer
Backgrounds Patients at greatest risk of severe clinical conditions from coronavirus disease
2019 (COVID-19) and death are elderly and comorbid patients. Increased levels of cardiac …

SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges

KS Shah, ME Hale Hammond, SG Drakos… - Future …, 2021 - Taylor & Francis
SARS-CoV-2 is responsible for the 2020 global COVID-19 pandemic. In patients with COVID-
19, multiple cardiovascular (CV) manifestations have been reported. SARS coronavirus 2 …

Inflammatory biomarkers and cardiac injury in COVID-19 patients

A Mumtaz, E Rehman, MA Rahaman… - Frontiers in Public …, 2022 - frontiersin.org
Introduction Cardiac injury has received considerable attention due to the higher risk of
morbidity and mortality associated with coronavirus disease. However, in a developing …

Immunological biomarkers of COVID-19

R Lei, C Mohan - Critical Reviews™ in Immunology, 2020 - dl.begellhouse.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the COVID-
19 pandemic, has become a global health emergency. The damage and threat posed by this …

[HTML][HTML] COVID-19 versus SARS: A comparative review

AS Keshta, SI Mallah, K Al Zubaidi, OK Ghorab… - Journal of Infection and …, 2021 - Elsevier
The two genetically similar severe acute respiratory syndrome coronaviruses, SARS-CoV-1
and SARS-CoV-2, have each been responsible for global epidemics of vastly different …